Clinical Trials Browser

Interventional × Has results × Squamous Non-small Cell Lung Cancer × Clear all

NCT01763788 2019-10-25

A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Completed

192 enrolled 24 charts

Squamous Non-small Cell Lung Cancer